T cells from SLE patients and murine models produce less IL-2 compared to normal controls, and lower IL-2 level in SLE patients with higher SLE Disease Activity Index (SLEDAI) [28, 29]. The gene discussed is IL2; the disease is systemic lupus erythematosus.